Skip to content

BAY3283142

DRUG6 trials

Sponsors

Bayer

Conditions

Arterial HypertensionChronic Kidney DiseaseHealthy VolunteersHepatic ImpairmentHypertensionNon-proliferative Diabetic Retinopathy

Phase 1

A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
CompletedNCT05491642
BayerChronic Kidney Disease, Hypertension
Start: 2022-09-08End: 2023-04-28Updated: 2023-05-17
A Study to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body, How it Moves Into, Through and Out of the Body When Single and Multiple Amounts Are Taken as Tablets in Japanese Healthy Male Participants
CompletedNCT05800444
BayerChronic Kidney Disease, Healthy Volunteers
Start: 2023-04-03End: 2023-07-19Updated: 2023-08-21
A Study to Learn About How BAY 3283142 Moves Into, Through, and Out of the Body After a Single Dose in Participants With Reduced Liver Function Compared to Participants With Normal Liver Function
CompletedNCT06402721
BayerChronic Kidney Disease, Hepatic Impairment
Start: 2024-05-17End: 2025-02-24Updated: 2025-03-12
A Study to Learn About the Safety of BAY3283142 in People With Mild to Moderate High Blood Pressure
CompletedNCT06428825
BayerArterial Hypertension, Chronic Kidney Disease
Start: 2024-08-16End: 2025-11-21Updated: 2026-06-16
A Study to Learn How Safe BAY3283142 is When Taken as a Single Dose or as Multiple Doses in Healthy Chinese Participants
CompletedNCT06487845
BayerChronic Kidney Disease, Healthy Volunteers, Non-proliferative Diabetic Retinopathy
Start: 2024-07-04End: 2024-09-19Updated: 2024-09-24

Phase 2